Nicotine receptor partial agonists for smoking cessation (1:30), primary aldosteronism (2:50), dual- vs. triple-combination inhalers for asthma (5:30), smell and taste disorders (9:40), finerenone (14:30), and diagnostic overshadowing (17:30).